AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
Seattle, Aug. 5 (Korea Bizwire) — AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of a state-of-the-art commercial manufacturing facility in Longmont, Colorado, USA. The facility, previously owned by Novartis Gene Therapies, will provide AGC Biologics with significant additional capacity and space to continue to [...]